Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study 
|2-8-1-1|1|557|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-2|1|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-3|1|599|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-4|1|691|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-5|1|753|Other deterministic changes|Lower respiratory system|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-6|1|782|Other deterministic changes|Lower respiratory system|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-7|1|835|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-8|1|855|Neoplasia malignant|Lower respiratory system|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-9|1|862|Neoplasia benign|Lower respiratory system|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-10|1|929|Other deterministic changes|Lower respiratory system|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-11|1|945|Neoplasia malignant|Lower respiratory system|n/a|
2-8-1|CmNOi-kBq 2.33,INII3AB/13 5/73|1| 92|Cm-244 nitrate|2.33|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-1-12|1|958|Neoplasia benign|Lower respiratory system|n/a|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-1|2|227|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-2|2|405|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-3|2|405|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-4|2|435|Neoplasia malignant|Lower respiratory system|n/a|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-5|2|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-6|2|439|Hyperplastic changes|Lower respiratory system|n/a|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-7|2|447|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-8|2|447|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-9|2|449|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-10|2|471|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-2|CmNOi-kBq 7.77,INII3AB/5 2/73|1| 92|Cm-244 nitrate|7.77|kilobecquerels|Inhalation| 5 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-2-11|2|773|Hyperplastic changes|Lower respiratory system|n/a|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-1|3|62|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-2|3|227|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-3|3|417|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-4|3|439|Other deterministic changes|Whole body|n/a|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-5|3|444|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-6|3|445|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-7|3|446|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-8|3|549|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-9|3|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-10|3|735|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-3|CmNOi-kBq 9.76,INII3AB/6 5/73|1| 92|Cm-244 nitrate|9.76|kilobecquerels|Inhalation| 6.3 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-3-11|3|739|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-1|4|8|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-2|4|36|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-3|4|85|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-4|4|87|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-5|4|207|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-6|4|214|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-7|4|348|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-8|4|390|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-9|4|418|Hyperplastic changes|Lower respiratory system|n/a|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-10|4|425|Hyperplastic changes|Lower respiratory system|n/a|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-11|4|425|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-12|4|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-13|4|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-14|4|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-15|4|426|Neoplasia benign|Lower respiratory system|n/a|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-16|4|433|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-17|4|433|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-18|4|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-19|4|435|Other deterministic changes|Whole body|n/a|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-20|4|438|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-21|4|451|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-4|CmNOi-kBq 13.6,INII3AB/8 +10 2/73|1| 92|Cm-244 nitrate|13.6|kilobecquerels|Inhalation| 8.8 Gy inhaled|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-4-22|4|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-1|5|54|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-2|5|65|Hyperplastic changes|Lower respiratory system|n/a|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-3|5|66|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-4|5|278|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-5|5|382|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-6|5|387|Hyperplastic changes|Lower respiratory system|n/a|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-7|5|395|Other deterministic changes|Whole body|n/a|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-8|5|427|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-5|CmNOi-kBq 23.7,INII3AB/11 4/73|1| 92|Cm-244 nitrate|23.7|kilobecquerels|Inhalation| 15.3 Gy inhaled|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-5-9|5|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-1|6|32|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-2|6|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-3|6|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-4|6|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-5|6|54|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-6|6|62|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-7|6|66|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-8|6|257|Other deterministic changes|Whole body|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-9|6|257|Other deterministic changes|Whole body|n/a|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-10|6|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-11|6|382|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-12|6|384|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-13|6|387|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-14|6|395|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-6|CmNOi-kBq 32.1,INII3AB/12 4/73|1| 92|Cm-244 nitrate|32.1|kilobecquerels|Inhalation| 20.7 Gy inhaled|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-6-15|6|404|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-1|7|24|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-2|7|42|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-3|7|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-4|7|59|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-5|7|62|Other deterministic changes|Whole body|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-6|7|71|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-7|7|72|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-8|7|73|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-9|7|193|Hyperplastic changes|Lower respiratory system|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-10|7|323|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-8-7|CmNOi-kBq 38.7,INII3AB/2 1/73|1| 92|Cm-244 nitrate|38.7|kilobecquerels|Inhalation| 25 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-7-11|7|341|Hyperplastic changes|Lower respiratory system|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-1|8|7|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-2|8|17|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-3|8|28|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-4|8|38|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-5|8|38|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-6|8|38|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-7|8|45|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-8|8|63|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-9|8|65|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-10|8|85|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-8|CmNOi-kBq 48,INII3AB/3 1/73|1| 92|Cm-244 nitrate|48|kilobecquerels|Inhalation| 31 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-8-11|8|204|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-1|9|55|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-2|9|85|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-3|9|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-4|9|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-5|9|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-6|9|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-7|9|439|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-8|9|458|Hyperplastic changes|Lower respiratory system|n/a|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-9|9|575|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-10|9|660|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|1| 92|Cm-244 nitrate|6.51|kilobecquerels|Inhalation| 4.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-11|9|789|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-1|9|55|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-2|9|85|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-3|9|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-4|9|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-5|9|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-6|9|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-7|9|439|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-8|9|458|Hyperplastic changes|Lower respiratory system|n/a|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-9|9|575|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-10|9|660|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-9|CmNOiDT-kBq 6.51,INII3AB/7 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-9-11|9|789|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-1|10|28|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-2|10|42|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-3|10|65|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-4|10|212|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-5|10|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-6|10|427|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-7|10|445|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-8|10|459|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-9|10|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-10|10|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|1| 92|Cm-244 nitrate|9.61|kilobecquerels|Inhalation| 6.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-11|10|784|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-1|10|28|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-2|10|42|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-3|10|65|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-4|10|212|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-5|10|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-6|10|427|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-7|10|445|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-8|10|459|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-9|10|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-10|10|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-10|CmNOiDT-kBq 9.61,INII3AB/9 2/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-10-11|10|784|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-1|11|71|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-2|11|193|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-3|11|291|Other deterministic changes|Lower respiratory system|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-4|11|416|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-5|11|458|Hyperplastic changes|Lower respiratory system|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-6|11|461|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|1| 92|Cm-244 nitrate|21.4|kilobecquerels|Inhalation| 13.8 Gy inhaled|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-7|11|466|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-1|11|71|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-2|11|193|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-3|11|291|Other deterministic changes|Lower respiratory system|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-4|11|416|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-5|11|458|Hyperplastic changes|Lower respiratory system|n/a|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-6|11|461|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-11|CmNOiDT-kBq 21.4,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|7 (7 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-11-7|11|466|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|1| 92|Cm-244 nitrate|30|kilobecquerels|Inhalation| 19.4 Gy inhaled|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-1|12|64|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|1| 92|Cm-244 nitrate|30|kilobecquerels|Inhalation| 19.4 Gy inhaled|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-2|12|70|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|1| 92|Cm-244 nitrate|30|kilobecquerels|Inhalation| 19.4 Gy inhaled|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-3|12|72|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|1| 92|Cm-244 nitrate|30|kilobecquerels|Inhalation| 19.4 Gy inhaled|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-4|12|76|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-1|12|64|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-2|12|70|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-3|12|72|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-12|CmNOiDT-kBq 30,INII3AB/1 1/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-12-4|12|76|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-1|13|14|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-2|13|16|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-3|13|22|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-4|13|22|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-5|13|24|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-6|13|24|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-7|13|24|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-8|13|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-9|13|64|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-10|13|66|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|1| 92|Cm-244 nitrate|59|kilobecquerels|Inhalation| 38.2 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-11|13|66|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-1|13|14|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-2|13|16|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-3|13|22|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-4|13|22|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-5|13|24|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-6|13|24|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-7|13|24|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-8|13|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-9|13|64|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-10|13|66|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-13|CmNOiDT-kBq 59,INII3AB/4 1/73|2| 92|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.immediat.|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-13-11|13|66|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-1|14|506|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-2|14|535|Neoplasia malignant|Lower respiratory system|n/a|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-3|14|535|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-4|14|543|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-5|14|543|Other deterministic changes|Whole body|n/a|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-6|14|561|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-7|14|590|Neoplasia malignant|Lower respiratory system|n/a|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-8|14|590|Hyperplastic changes|Lower respiratory system|n/a|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-9|14|624|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-10|14|624|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-11|14|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-12|14|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-13|14|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-14|14|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-15|14|644|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-16|14|647|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-17|14|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-18|14|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-19|14|700|Neoplasia benign|Lower respiratory system|n/a|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-20|14|700|Neoplasia benign|Lower respiratory system|n/a|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-21|14|703|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-22|14|746|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-23|14|786|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-14|ThCli-kBq 8,INII3AB/2-3 12/73|1| 92|Th-227 chloride|8|kilobecquerels|Inhalation| 3.1 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-14-24|14|788|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-1|15|529|Other deterministic changes|Whole body|n/a|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-2|15|552|Hyperplastic changes|Lower respiratory system|n/a|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-3|15|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-4|15|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-5|15|561|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-6|15|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-7|15|589|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-8|15|634|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-9|15|651|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-10|15|654|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-11|15|739|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-15|ThCli-kBq 17.8,INII3AB/1 12/73|1| 92|Th-227 chloride|17.8|kilobecquerels|Inhalation| 9.2 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-15-12|15|783|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-1|16|367|Other deterministic changes|Whole body|n/a|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-2|16|417|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-3|16|485|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-4|16|488|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-5|16|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-6|16|507|Hyperplastic changes|Lower respiratory system|n/a|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-7|16|510|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-8|16|537|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-9|16|540|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-10|16|549|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-11|16|619|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-12|16|625|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-13|16|628|Hyperplastic changes|Lower respiratory system|n/a|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-14|16|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-15|16|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-16|16|643|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-17|16|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-18|16|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-19|16|663|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-20|16|675|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-21|16|678|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-22|16|678|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-23|16|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-16|AmNOi-kBq 0.67,INII4AB/40+43 4/73|1| 92|Am-241 nitrate|0.67|kilobecquerels|Inhalation| 0.52 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-16-24|16|691|Hyperplastic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-1|17|294|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-2|17|418|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-3|17|424|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-4|17|428|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-5|17|453|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-6|17|459|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-7|17|485|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-8|17|518|Neoplasia malignant|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-9|17|520|Other deterministic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-10|17|527|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-11|17|529|Hyperplastic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-12|17|533|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-13|17|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-14|17|572|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-15|17|577|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-16|17|583|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-17|17|585|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-18|17|591|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-19|17|593|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-20|17|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-21|17|595|Hyperplastic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-22|17|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-23|17|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-24|17|613|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-25|17|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-26|17|620|Hyperplastic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-27|17|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-28|17|637|Hyperplastic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-29|17|659|Hyperplastic changes|Lower respiratory system|n/a|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-30|17|664|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-31|17|665|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-32|17|665|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-33|17|682|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-34|17|692|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-35|17|747|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-17|AmNOi-kBq 0.81,INII4AB/52+55+58 7/74|1| 92|Am-241 nitrate|0.81|kilobecquerels|Inhalation| 0.65 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-17-36|17|747|Hyperplastic changes|Lower respiratory system|n/a|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-1|18|294|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-2|18|389|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-3|18|454|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-4|18|463|Other deterministic changes|Whole body|n/a|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-5|18|503|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-6|18|507|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-7|18|522|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-8|18|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 551 - sarcoma|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-9|18|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-10|18|576|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-11|18|594|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-12|18|594|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-13|18|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-14|18|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-15|18|612|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-16|18|612|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-17|18|613|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-18|18|614|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-19|18|620|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-20|18|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-21|18|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-22|18|677|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-23|18|678|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-18|AmNOi-kBq 1.0,INII4AB/36+54 4/74|1| 92|Am-241 nitrate|1|kilobecquerels|Inhalation| 0.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-18-24|18|691|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-1|19|463|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-2|19|477|Other deterministic changes|Whole body|n/a|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-3|19|509|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-4|19|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-5|19|555|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-6|19|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-7|19|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-8|19|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-9|19|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-10|19|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-11|19|582|Hyperplastic changes|Lower respiratory system|n/a|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-12|19|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-13|19|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-14|19|597|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-15|19|613|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-16|19|613|Hyperplastic changes|Lower respiratory system|n/a|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-17|19|613|Hyperplastic changes|Lower respiratory system|n/a|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-18|19|643|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-19|19|667|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-20|19|678|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-21|19|679|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-22|19|712|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-23|19|723|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-19|AmNOi-kBq 1.11,INII4AB/41+47 4/74|1| 92|Am-241 nitrate|1.11|kilobecquerels|Inhalation| 0.9 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-19-24|19|792|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-1|20|266|Other deterministic changes|Whole body|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-2|20|382|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-3|20|406|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-4|20|424|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-5|20|426|Hyperplastic changes|Lower respiratory system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-6|20|432|Hyperplastic changes|Lower respiratory system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-7|20|435|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-8|20|451|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-9|20|476|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-10|20|480|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-11|20|481|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-12|20|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-13|20|508|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-14|20|525|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-15|20|531|Hyperplastic changes|Lower respiratory system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-16|20|533|Other deterministic changes|Whole body|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-17|20|540|Neoplasia malignant|Lower respiratory system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-18|20|540|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-19|20|540|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-20|20|546|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-21|20|553|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-22|20|557|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-23|20|558|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-24|20|558|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-25|20|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-26|20|561|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-27|20|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-28|20|569|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-29|20|577|Other deterministic changes|Whole body|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-30|20|583|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-31|20|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-32|20|591|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-33|20|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-34|20|593|Hyperplastic changes|Lower respiratory system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-35|20|593|Hyperplastic changes|Lower respiratory system|n/a|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-36|20|604|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 491 - polyp|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-37|20|607|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-38|20|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-39|20|617|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-40|20|630|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-41|20|630|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-42|20|630|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-43|20|649|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-44|20|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-45|20|658|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-46|20|659|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-47|20|719|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-20|AmNOi-kBq 1.26,INII4AB/42+46+56+44 4/74|1| 92|Am-241 nitrate|1.26|kilobecquerels|Inhalation| 1.05 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-20-48|20|719|Hyperplastic changes|Lower respiratory system|n/a|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-1|21|346|Other deterministic changes|Whole body|n/a|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-2|21|384|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-3|21|488|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-4|21|500|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-5|21|503|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-6|21|507|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-7|21|527|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-8|21|548|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-9|21|549|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-10|21|566|Other deterministic changes|Whole body|n/a|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-11|21|568|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-12|21|570|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-13|21|571|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-14|21|577|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system| benign,MPATH: 551 - sarcoma|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-15|21|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-16|21|584|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 551 - sarcoma|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-17|21|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-18|21|589|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-19|21|594|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-20|21|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-21|21|601|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-22|21|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-23|21|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-24|21|613|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-25|21|613|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-26|21|613|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-27|21|614|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-28|21|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-29|21|621|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-30|21|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-31|21|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-32|21|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-33|21|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-34|21|656|Other deterministic changes|Whole body|n/a|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-35|21|657|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-36|21|659|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-37|21|682|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-38|21|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-39|21|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-40|21|684|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-41|21|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-42|21|691|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-43|21|692|Hyperplastic changes|Lower respiratory system|n/a|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-44|21|712|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-45|21|712|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-46|21|727|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-47|21|745|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-21|AmNOi-kBq 1.52,INII4AB/37+38+39+53 4/74|1| 92|Am-241 nitrate|1.52|kilobecquerels|Inhalation| 1.21 Gy inhaled|48 (48 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-21-48|21|746|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-1|22|377|Other deterministic changes|Whole body|n/a|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-2|22|417|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-3|22|426|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-4|22|485|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-5|22|506|Other deterministic changes|Whole body|n/a|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-6|22|519|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-7|22|557|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-8|22|557|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-9|22|571|Neoplasia malignant|Lower respiratory system|n/a|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-10|22|573|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-11|22|585|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-12|22|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-13|22|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-14|22|589|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-15|22|589|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-16|22|590|Hyperplastic changes|Lower respiratory system|n/a|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-17|22|620|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-18|22|622|Other deterministic changes|Whole body|n/a|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-19|22|636|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-20|22|659|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-21|22|680|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-22|22|680|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-23|22|735|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-22|AmNOi-kBq 1.66,INII4AB/30+57 3/74|1| 92|Am-241 nitrate|1.66|kilobecquerels|Inhalation| 1.37 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-22-24|22|747|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-1|23|390|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-2|23|507|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-3|23|528|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-4|23|541|Other deterministic changes|Whole body|n/a|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-5|23|568|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-6|23|578|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-7|23|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-8|23|585|Neoplasia malignant|Lower respiratory system|n/a|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-9|23|606|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| benign,MPATH: 549 - carcinoma|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-10|23|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-11|23|628|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-23|AmNOi-kBq 1.81,INII4AB/29 3/74|1| 92|Am-241 nitrate|1.81|kilobecquerels|Inhalation| 1.5 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-23-12|23|711|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-1|24|379|Other deterministic changes|Whole body|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-2|24|464|Other deterministic changes|Whole body|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-3|24|489|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-4|24|498|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-5|24|509|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-6|24|527|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-7|24|532|Other deterministic changes|Whole body|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-8|24|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-9|24|547|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-10|24|553|Other deterministic changes|Whole body|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-11|24|553|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-12|24|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-13|24|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-14|24|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-15|24|571|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-16|24|578|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-17|24|579|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-18|24|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-19|24|582|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-20|24|590|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-21|24|604|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-22|24|613|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-23|24|613|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-24|24|620|Neoplasia malignant|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-25|24|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-26|24|627|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-27|24|645|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-28|24|649|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-29|24|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-30|24|666|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-31|24|677|Neoplasia benign|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-32|24|680|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-33|24|692|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-34|24|698|Hyperplastic changes|Lower respiratory system|n/a|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-35|24|699|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-24|AmNOi-kBq 2.22,INII4AB/28+34+59 7/74|1| 92|Am-241 nitrate|2.22|kilobecquerels|Inhalation| 1.78 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-24-36|24|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-1|25|353|Other deterministic changes|Lower respiratory system|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-2|25|390|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-3|25|399|Other deterministic changes|Whole body|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-4|25|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-5|25|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-6|25|494|Other deterministic changes|Whole body|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-7|25|501|Neoplasia malignant|Lower respiratory system|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-8|25|514|Other deterministic changes|Whole body|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-9|25|534|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-10|25|547|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-11|25|572|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-12|25|577|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-13|25|590|Neoplasia benign|Lower respiratory system|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-14|25|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-15|25|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-16|25|598|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-17|25|598|Hyperplastic changes|Lower respiratory system|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-18|25|602|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-19|25|603|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-20|25|603|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-21|25|613|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-22|25|621|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-23|25|622|Other deterministic changes|Lower respiratory system|n/a|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-24|25|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-25|25|634|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-26|25|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-27|25|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-28|25|653|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-29|25|658|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-30|25|660|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-31|25|678|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-32|25|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-33|25|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-34|25|692|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-35|25|763|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-25|AmNOi-kBq 2.44,INII4AB/32+33+35 3/74|1| 92|Am-241 nitrate|2.44|kilobecquerels|Inhalation| 2 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-25-36|25|763|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-1|26|438|Neoplasia benign|Lower respiratory system|n/a|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-2|26|453|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-3|26|475|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-4|26|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-5|26|491|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-6|26|492|Other deterministic changes|Lower respiratory system|n/a|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-7|26|500|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-8|26|504|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-9|26|507|Neoplasia benign|Upper respiratory system,MA: 0000441 - trachea|,MPATH: 445 - papilloma|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-10|26|508|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-11|26|529|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-12|26|540|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-13|26|555|Other deterministic changes|Whole body|n/a|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-14|26|560|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-15|26|571|Neoplasia malignant|Lower respiratory system|n/a|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-16|26|572|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-17|26|581|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-18|26|590|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-19|26|590|Hyperplastic changes|Lower respiratory system|n/a|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-20|26|595|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-21|26|599|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-22|26|612|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-23|26|617|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-24|26|620|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-25|26|624|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-26|26|630|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-27|26|642|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-28|26|644|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-29|26|665|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-30|26|669|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-31|26|677|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-32|26|683|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-33|26|684|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-34|26|699|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-26|AmNOi-kBq 2.77,INII4AB/31+45+48 6/74|1| 92|Am-241 nitrate|2.77|kilobecquerels|Inhalation| 2.3 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-26-35|26|706|Neoplasia benign|Lower respiratory system|n/a|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-1|27|420|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-2|27|425|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-3|27|453|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-4|27|494|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-5|27|496|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-6|27|503|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system| metastatic,MPATH: 551 - sarcoma|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-7|27|508|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-8|27|527|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-9|27|532|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-10|27|544|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-11|27|554|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-12|27|559|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-13|27|560|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-14|27|568|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-15|27|572|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-16|27|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-17|27|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-18|27|599|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-19|27|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-20|27|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-21|27|612|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-22|27|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-23|27|622|Neoplasia malignant|Lower respiratory system|n/a|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-24|27|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-25|27|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-26|27|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-27|27|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-28|27|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-29|27|641|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-30|27|643|Hyperplastic changes|Lower respiratory system|n/a|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-31|27|659|Neoplasia malignant|Lower respiratory system|n/a|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-32|27|720|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-33|27|748|Neoplasia malignant|Lower respiratory system|n/a|
2-8-27|AmNOi-kBq 3.7,INII4AB/49+50+51 6/74|1| 92|Am-241 nitrate|3.7|kilobecquerels|Inhalation| 3 Gy inhaled|36 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-27-34|27|772|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-1|28|607|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-2|28|617|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-3|28|659|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-4|28|690|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-5|28|694|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-6|28|706|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-7|28|722|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-8|28|732|Other deterministic changes|Lower respiratory system|n/a|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-9|28|742|Other deterministic changes|Lower respiratory system|n/a|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-10|28|752|Other deterministic changes|Lower respiratory system|n/a|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-11|28|765|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-28|AmNOi-kBq 4.81,INII4AB/4 9/72|1| 92|Am-241 nitrate|4.81|kilobecquerels|Inhalation| 4 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-28-12|28|774|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-1|29|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-2|29|387|Neoplasia benign|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-3|29|405|Other deterministic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-4|29|462|Hyperplastic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-5|29|492|Hyperplastic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-6|29|492|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-7|29|517|Other deterministic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-8|29|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-9|29|552|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-10|29|554|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-11|29|556|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-12|29|557|Other deterministic changes|Whole body|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-13|29|560|Neoplasia benign|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-14|29|565|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-15|29|565|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-16|29|565|Hyperplastic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-17|29|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-18|29|582|Other deterministic changes|Whole body|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-19|29|592|Other deterministic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-20|29|604|Neoplasia malignant|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-21|29|612|Neoplasia malignant|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-22|29|614|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-23|29|627|Neoplasia benign|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-24|29|627|Neoplasia benign|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-25|29|627|Hyperplastic changes|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-26|29|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-27|29|629|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-28|29|634|Neoplasia malignant|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-29|29|635|Neoplasia malignant|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-30|29|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-31|29|639|Neoplasia benign|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-32|29|715|Neoplasia malignant|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-33|29|722|Neoplasia malignant|Lower respiratory system|n/a|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-34|29|742|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-35|29|750|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-29|AmNOi-kBq 7.4,INII4AB/1+3+22 71-72|1| 92|Am-241 nitrate|7.4|kilobecquerels|Inhalation| 6.4 Gy inhaled|34 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-29-36|29|750|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-1|30|284|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-2|30|324|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-3|30|456|Other deterministic changes|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-4|30|486|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-5|30|532|Other deterministic changes|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-6|30|559|Neoplasia benign|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-7|30|566|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-8|30|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-9|30|601|Neoplasia benign|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-10|30|601|Neoplasia benign|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-11|30|606|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-12|30|618|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-13|30|625|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-14|30|634|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-15|30|637|Neoplasia malignant|Reproductive system,MA: 0000411 - testis|,MPATH: 218 - neoplasm|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-16|30|638|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-17|30|656|Neoplasia benign|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-18|30|656|Neoplasia malignant|Lower respiratory system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-19|30|658|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-20|30|668|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-21|30|677|Neoplasia malignant|Spleen and thymus  among haematolymphatic system|n/a|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-22|30|691|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-23|30|708|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-30|AmNOi-kBq 11.8,INII4AB/24+20 2/74|1| 92|Am-241 nitrate|11.8|kilobecquerels|Inhalation| 9.7 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan studyy|2-8-30-24|30|734|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| metastatic,MPATH: 549 - carcinoma|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-1|31|211|Other deterministic changes|Whole body|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-2|31|312|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-3|31|340|Other deterministic changes|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-4|31|350|Neoplasia malignant|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-5|31|488|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-6|31|499|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-7|31|499|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-8|31|502|Other deterministic changes|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-9|31|522|Hyperplastic changes|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-10|31|529|Hyperplastic changes|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-11|31|529|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-12|31|534|Neoplasia malignant|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-13|31|535|Hyperplastic changes|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-14|31|554|Neoplasia benign|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-15|31|559|Other deterministic changes|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-16|31|560|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-17|31|562|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-18|31|563|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-19|31|563|Neoplasia malignant|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-20|31|563|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-21|31|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-22|31|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-23|31|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-24|31|593|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-25|31|596|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-26|31|596|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-27|31|596|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-28|31|597|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-29|31|603|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-30|31|606|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-31|31|617|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-32|31|618|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-33|31|629|Neoplasia malignant|Lower respiratory system|n/a|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-34|31|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-31|AmNOi-kBq 18.1,INII4AB/23+26+27 2/74|1| 92|Am-241 nitrate|18.1|kilobecquerels|Inhalation| 14.7 Gy inhaled|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-31-35|31|638|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-1|32|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-2|32|397|Other deterministic changes|Whole body|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-3|32|400|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-4|32|465|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-5|32|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-6|32|502|Hyperplastic changes|Lower respiratory system|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-7|32|519|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-8|32|528|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-9|32|530|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-10|32|538|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-11|32|538|Other deterministic changes|Lower respiratory system|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-12|32|538|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-13|32|549|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-14|32|552|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-15|32|558|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-16|32|560|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-17|32|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-18|32|564|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-19|32|565|Neoplasia malignant|Lower respiratory system|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-20|32|565|Hyperplastic changes|Lower respiratory system|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-21|32|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-22|32|603|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-23|32|606|Neoplasia malignant|Lower respiratory system|n/a|
2-8-32|AmNOi-kBq 22.2,INII4AB/21+25 2/74|1| 92|Am-241 nitrate|22.2|kilobecquerels|Inhalation| 18.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-32-24|32|739|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-1|33|344|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-2|33|392|Other deterministic changes|Lower respiratory system|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-3|33|402|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-4|33|426|Hyperplastic changes|Lower respiratory system|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-5|33|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-6|33|468|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-7|33|484|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-8|33|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-9|33|531|Neoplasia malignant|Lower respiratory system|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-10|33|556|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-11|33|616|Neoplasia malignant|Lower respiratory system|n/a|
2-8-33|AmNOi-kBq 31.1,INII4AB/6 6/72|1| 92|Am-241 nitrate|31.1|kilobecquerels|Inhalation| 25 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-33-12|33|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-1|34|35|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-2|34|37|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-3|34|40|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-4|34|43|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-5|34|44|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-6|34|54|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-7|34|57|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-8|34|64|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-9|34|64|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-10|34|68|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-11|34|73|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-12|34|73|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-13|34|75|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-14|34|79|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-15|34|196|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-16|34|196|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-17|34|293|Other deterministic changes|Whole body|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-18|34|470|Neoplasia benign|Lower respiratory system|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-19|34|477|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-20|34|477|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-21|34|478|Hyperplastic changes|Lower respiratory system|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-22|34|510|Hyperplastic changes|Lower respiratory system|n/a|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-23|34|511|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-24|34|585|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-34|AmNOi-kBq 51.8,INII4AB/11+15 1/74|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 39 Gy inhaled|25 (25 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-34-25|34|596|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-1|35|34|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-2|35|34|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-3|35|35|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-4|35|35|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-5|35|35|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-6|35|40|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-7|35|41|Other deterministic changes|Whole body|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-8|35|46|Other deterministic changes|Whole body|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-9|35|46|Other deterministic changes|Whole body|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-10|35|54|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-11|35|54|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-12|35|55|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-13|35|55|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-14|35|55|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-15|35|55|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-16|35|59|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-17|35|59|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-18|35|61|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-19|35|67|Other deterministic changes|Whole body|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-20|35|68|Other deterministic changes|Whole body|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-21|35|192|Other deterministic changes|Whole body|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-22|35|198|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-23|35|249|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-24|35|252|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-25|35|279|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-26|35|321|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-27|35|392|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-28|35|392|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-35|AmNOi-kBq 104,INII4AB/10+14+16 1/74|1| 92|Am-241 nitrate|104|kilobecquerels|Inhalation| 58 Gy inhaled|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-35-29|35|426|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-1|36|289|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-2|36|472|Hyperplastic changes|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-3|36|474|Other deterministic changes|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-4|36|480|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-5|36|512|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-6|36|526|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-7|36|564|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-8|36|575|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-9|36|577|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-10|36|607|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-11|36|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-12|36|613|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-13|36|616|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-14|36|636|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-15|36|639|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-16|36|640|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-17|36|649|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-18|36|655|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-19|36|655|Neoplasia benign|Bloodvessels among cardiovascular system| benign|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-20|36|680|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-21|36|704|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-22|36|724|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-23|36|732|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|1| 92|Am-241 nitrate|25.1|kilobecquerels|Inhalation| 19 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-24|36|732|Neoplasia malignant|Lower respiratory system| metastatic lung tumour|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-1|36|289|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-2|36|472|Hyperplastic changes|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-3|36|474|Other deterministic changes|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-4|36|480|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-5|36|512|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-6|36|526|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-7|36|564|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-8|36|575|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-9|36|577|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-10|36|607|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-11|36|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-12|36|613|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-13|36|616|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-14|36|636|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-15|36|639|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-16|36|640|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-17|36|649|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-18|36|655|Neoplasia malignant|Lower respiratory system|n/a|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-19|36|655|Neoplasia benign|Bloodvessels among cardiovascular system| benign|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-20|36|680|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-21|36|704|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-22|36|724|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-23|36|732|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-36|AmNOiDT-kBq 25.1,INII4AB/2+5 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-36-24|36|732|Neoplasia malignant|Lower respiratory system| metastatic lung tumour|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-1|37|48|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-2|37|67|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-3|37|69|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-4|37|82|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-5|37|197|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-6|37|252|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-7|37|272|Hyperplastic changes|Lower respiratory system|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-8|37|280|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-9|37|289|Neoplasia benign|Lower respiratory system|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-10|37|312|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-11|37|475|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|1| 92|Am-241 nitrate|59.2|kilobecquerels|Inhalation| 40 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-12|37|517|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-1|37|48|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-2|37|67|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-3|37|69|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-4|37|82|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-5|37|197|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-6|37|252|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-7|37|272|Hyperplastic changes|Lower respiratory system|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-8|37|280|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-9|37|289|Neoplasia benign|Lower respiratory system|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-10|37|312|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-11|37|475|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-37|AmNOiDT-kBq 59.2,INII4AB/7 9/72|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-37-12|37|517|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-1|38|47|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-2|38|47|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-3|38|62|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-4|38|62|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-5|38|69|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-6|38|73|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-7|38|90|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-8|38|212|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-9|38|252|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-10|38|288|Hyperplastic changes|Lower respiratory system|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-11|38|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|1| 92|Am-241 nitrate|74|kilobecquerels|Inhalation| 41 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-12|38|512|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-1|38|47|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-2|38|47|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-3|38|62|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-4|38|62|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-5|38|69|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-6|38|73|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-7|38|90|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-8|38|212|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-9|38|252|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-10|38|288|Hyperplastic changes|Lower respiratory system|n/a|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-11|38|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-38|AmNOiDT-kBq 74,INII4AB/8+8 9/72|2| 103|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-38-12|38|512|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-1|39|89|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-2|39|232|Neoplasia benign|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-3|39|311|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-4|39|330|Hyperplastic changes|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-5|39|344|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-6|39|417|Hyperplastic changes|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-7|39|438|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-8|39|447|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 235 - blood vessel tumor|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-9|39|537|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-10|39|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-11|39|607|Neoplasia malignant|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|1| 92|Am-241 nitrate|51.8|kilobecquerels|Inhalation| 36 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-12|39|637|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-1|39|89|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-2|39|232|Neoplasia benign|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-3|39|311|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-4|39|330|Hyperplastic changes|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-5|39|344|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-6|39|417|Hyperplastic changes|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-7|39|438|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-8|39|447|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 235 - blood vessel tumor|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-9|39|537|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-10|39|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-11|39|607|Neoplasia malignant|Lower respiratory system|n/a|
2-8-39|AmNOiDT-kBq 51.8,INII4AB/9 9/72|2| 111|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-39-12|39|637|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-1|40|62|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-2|40|67|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-3|40|196|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-4|40|200|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-5|40|212|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-6|40|216|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-7|40|234|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-8|40|239|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-9|40|248|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-10|40|256|Neoplasia benign|Lower respiratory system|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-11|40|261|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|1| 92|Am-241 nitrate|113|kilobecquerels|Inhalation| 42 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-12|40|262|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-1|40|62|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-2|40|67|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-3|40|196|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-4|40|200|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-5|40|212|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-6|40|216|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-7|40|234|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-8|40|239|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-9|40|248|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-10|40|256|Neoplasia benign|Lower respiratory system|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-11|40|261|Other deterministic changes|Whole body|n/a|
2-8-40|AmNOiDT-kBq 113,INII4AB/12 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-40-12|40|262|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-1|41|34|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-2|41|52|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-3|41|55|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-4|41|56|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-5|41|63|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-6|41|63|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-7|41|65|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-8|41|77|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-9|41|87|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-10|41|193|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-11|41|213|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|1| 92|Am-241 nitrate|190|kilobecquerels|Inhalation| 67 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-12|41|213|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-1|41|34|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-2|41|52|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-3|41|55|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-4|41|56|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-5|41|63|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-6|41|63|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-7|41|65|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-8|41|77|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-9|41|87|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-10|41|193|Other deterministic changes|Whole body|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-11|41|213|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-41|AmNOiDT-kBq 190,INII4AB/13 9/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-41-12|41|213|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-1|42|287|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-2|42|289|Neoplasia malignant|Reproductive system,MA: 0000411 - testis| benign,MPATH: 218 - neoplasm|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-3|42|304|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-4|42|526|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-5|42|648|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-6|42|666|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-7|42|712|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-8|42|736|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-9|42|736|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-10|42|749|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-11|42|762|Other deterministic changes|Whole body|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-12|42|766|Other deterministic changes|Whole body|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-13|42|772|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-14|42|782|Other deterministic changes|Whole body|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-15|42|791|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-16|42|792|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-17|42|792|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-18|42|795|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-19|42|805|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-20|42|813|Other deterministic changes|Whole body|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-21|42|817|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-22|42|829|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-23|42|830|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-24|42|842|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-25|42|842|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-26|42|842|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-27|42|842|Other deterministic changes|Lower respiratory system|n/a|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-28|42|866|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-29|42|866|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-42|AmNOiTO-kBq 0,TEM6 1/74|1| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-42-30|42|876|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-1|43|324|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-2|43|590|Neoplasia malignant|Lower respiratory system|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-3|43|618|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-4|43|635|Neoplasia malignant|Lower respiratory system|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-5|43|679|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-6|43|730|Neoplasia malignant|Lower respiratory system| metastatic lung tumour|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-7|43|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-8|43|741|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-9|43|745|Neoplasia malignant|Lower respiratory system|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-10|43|745|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|1| 92|Am-241 nitrate|10.7|kilobecquerels|Inhalation| 8.9 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-11|43|772|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| metastatic,MPATH: 268 - adenocarcinoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-1|43|324|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-2|43|590|Neoplasia malignant|Lower respiratory system|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-3|43|618|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-4|43|635|Neoplasia malignant|Lower respiratory system|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-5|43|679|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 219 - adnexal and skin appendage tumor|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-6|43|730|Neoplasia malignant|Lower respiratory system| metastatic lung tumour|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-7|43|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-8|43|741|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-9|43|745|Neoplasia malignant|Lower respiratory system|n/a|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-10|43|745|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-43|AmNOiTO-kBq 10.7,INII4AB/17 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-43-11|43|772|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| metastatic,MPATH: 268 - adenocarcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-1|44|331|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-2|44|397|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-3|44|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-4|44|516|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-5|44|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-6|44|569|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-7|44|583|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-8|44|609|Neoplasia benign|Lower respiratory system|n/a|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-9|44|615|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|1| 92|Am-241 nitrate|15.5|kilobecquerels|Inhalation| 12.5 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-10|44|645|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-1|44|331|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-2|44|397|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-3|44|496|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-4|44|516|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-5|44|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-6|44|569|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-7|44|583|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-8|44|609|Neoplasia benign|Lower respiratory system|n/a|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-9|44|615|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-44|AmNOiTO-kBq 15.5,INII4AB/18 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-44-10|44|645|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-1|45|443|Neoplasia benign|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-2|45|519|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-3|45|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-4|45|560|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-5|45|569|Hyperplastic changes|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-6|45|605|Neoplasia benign|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-7|45|608|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-8|45|609|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-9|45|737|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|1| 92|Am-241 nitrate|18.5|kilobecquerels|Inhalation| 15 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-10|45|763|Neoplasia malignant|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-1|45|443|Neoplasia benign|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-2|45|519|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-3|45|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-4|45|560|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-5|45|569|Hyperplastic changes|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-6|45|605|Neoplasia benign|Lower respiratory system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-7|45|608|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-8|45|609|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-9|45|737|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-45|AmNOiTO-kBq 18.5,INII4AB/19 1/74|2| 92|tobacco smoke||unit code not relevant|Inhalation| inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-45-10|45|763|Neoplasia malignant|Lower respiratory system|n/a|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-1|46|309|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-2|46|338|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-3|46|339|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-4|46|340|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-5|46|340|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-6|46|345|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-7|46|349|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-8|46|353|Other deterministic changes|Whole body|n/a|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-9|46|370|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-10|46|387|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-11|46|409|Other deterministic changes|Whole body|n/a|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-12|46|562|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-13|46|571|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland| benign,MPATH: 549 - carcinoma|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-14|46|597|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-15|46|597|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-16|46|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-17|46|683|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-18|46|686|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-19|46|686|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-20|46|774|Neoplasia malignant|Lower respiratory system|n/a|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-21|46|821|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-22|46|831|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-23|46|882|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-46|AmOi-kBq 1.66,INII4AB/2+9 5/73|1| 92|Am-241 oxide|1.66|kilobecquerels|Inhalation| 1.2 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-46-24|46|921|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-1|47|508|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-2|47|512|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-3|47|562|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-4|47|567|Neoplasia benign|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-5|47|618|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-6|47|618|Neoplasia malignant|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-7|47|633|Neoplasia benign|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-8|47|642|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-9|47|651|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-10|47|670|Hyperplastic changes|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-11|47|671|Neoplasia malignant|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-12|47|694|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-13|47|694|Neoplasia malignant|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-14|47|707|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-15|47|707|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-16|47|721|Neoplasia malignant|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-17|47|744|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract| metastatic,MPATH: 549 - carcinoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-18|47|746|Neoplasia benign|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-19|47|792|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-20|47|792|Neoplasia malignant|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-21|47|792|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-22|47|802|Neoplasia benign|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-23|47|814|Neoplasia malignant|Lower respiratory system|n/a|
2-8-47|AmOi9m-kBq 10,INII4AB/15+16 11/73|1| 276|Am-241 oxide|10|kilobecquerels|Inhalation| 5.3 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-47-24|47|825|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-1|48|84|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-2|48|400|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 426 - leiomyosarcoma|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-3|48|584|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-4|48|592|Neoplasia malignant|Integumentary system,MA: 0000151 - skin| metastatic,MPATH: 446 - squamous cell carcinoma|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-5|48|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-6|48|677|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-7|48|700|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-8|48|718|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-9|48|780|Hyperplastic changes|Lower respiratory system|n/a|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-10|48|782|Neoplasia malignant|Lower respiratory system|n/a|
2-8-48|AmOi-kBq 8.62,INII4AB/1 3/73|1| 92|Am-241 oxide|8.62|kilobecquerels|Inhalation| 6.7 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-48-11|48|782|Neoplasia malignant|Lower respiratory system|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-1|49|43|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-2|49|50|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-3|49|55|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-4|49|337|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-5|49|342|Other deterministic changes|Whole body|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-6|49|347|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-7|49|360|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-8|49|360|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-9|49|360|Hyperplastic changes|Lower respiratory system|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-10|49|381|Neoplasia benign|Lower respiratory system|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-11|49|465|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-12|49|521|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-13|49|526|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-14|49|547|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-15|49|554|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-16|49|555|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-17|49|561|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-18|49|600|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-19|49|629|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-20|49|637|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-21|49|674|Neoplasia malignant|Lower respiratory system|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-22|49|696|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-23|49|704|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-24|49|715|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-25|49|715|Neoplasia malignant|Lower respiratory system|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-26|49|715|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-27|49|716|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-28|49|730|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-29|49|736|Neoplasia malignant|Lower respiratory system|n/a|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-30|49|736|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-31|49|746|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-32|49|754|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-33|49|759|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-49|AmOi-kBq 10,INII4AB/11+12+10 6/73|1| 92|Am-241 oxide|10|kilobecquerels|Inhalation| 9.3 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-49-34|49|760|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-1|50|41|Other deterministic changes|Whole body|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-2|50|342|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-3|50|363|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-4|50|379|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-5|50|419|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-6|50|462|Other deterministic changes|Whole body|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-7|50|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-8|50|508|Other deterministic changes|Lower respiratory system|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-9|50|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-10|50|585|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-11|50|592|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-12|50|608|Neoplasia malignant|Lower respiratory system|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-13|50|612|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-14|50|637|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-15|50|708|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-16|50|709|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-17|50|715|Neoplasia malignant|Lower respiratory system|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-18|50|721|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-19|50|723|Neoplasia malignant|Lower respiratory system|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-20|50|723|Neoplasia malignant|Reproductive system,MA: 0000411 - testis|,MPATH: 218 - neoplasm|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-21|50|742|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| metastatic,MPATH: 268 - adenocarcinoma|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-22|50|759|Neoplasia malignant|Lower respiratory system|n/a|
2-8-50|AmOi-kBq 18.5,INII4AB/5+8 5/73|1| 92|Am-241 oxide|18.5|kilobecquerels|Inhalation| 15.6 Gy inhaled|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-50-23|50|778|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-1|51|49|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-2|51|59|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-3|51|66|Other deterministic changes|Whole body|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-4|51|239|Hyperplastic changes|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-5|51|273|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-6|51|282|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-7|51|298|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-8|51|316|Hyperplastic changes|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-9|51|330|Neoplasia benign|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-10|51|352|Neoplasia malignant|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-11|51|353|Hyperplastic changes|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-12|51|362|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 491 - polyp|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-13|51|376|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-14|51|382|Hyperplastic changes|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-15|51|382|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-16|51|388|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-17|51|403|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-18|51|422|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-19|51|468|Hyperplastic changes|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-20|51|493|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-21|51|541|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-22|51|543|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-23|51|637|Neoplasia malignant|Lower respiratory system|n/a|
2-8-51|AmOi-kBq 24.4,INII4AB/4+7 5/73|1| 92|Am-241 oxide|24.4|kilobecquerels|Inhalation| 28 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-51-24|51|639|Neoplasia malignant|Lower respiratory system|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-1|52|22|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-2|52|28|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-3|52|33|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-4|52|34|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-5|52|37|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-6|52|37|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-7|52|37|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-8|52|44|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-9|52|48|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-10|52|48|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-11|52|51|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-12|52|51|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-13|52|57|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-14|52|59|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-15|52|77|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-16|52|79|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-17|52|212|Hyperplastic changes|Lower respiratory system|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-18|52|215|Hyperplastic changes|Lower respiratory system|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-19|52|242|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-20|52|250|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-21|52|348|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-22|52|348|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-23|52|389|Neoplasia benign|Lower respiratory system|n/a|
2-8-52|AmOi-kBq 55.5,INII4AB/3+6+6 5/73|1| 92|Am-241 oxide|55.5|kilobecquerels|Inhalation| 53 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|200 g weight Lifespan study|2-8-52-24|52|389|Neoplasia benign|Lower respiratory system|n/a|
2-8-53|AmOi-kBq 851,INII4AB/13+13b 11/73|1| 92|Am-241 oxide|851|kilobecquerels|Inhalation| 241 Gy inhaled|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-53-1|53|2|Other deterministic changes|Whole body|n/a|
2-8-53|AmOi-kBq 851,INII4AB/13+13b 11/73|1| 92|Am-241 oxide|851|kilobecquerels|Inhalation| 241 Gy inhaled|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-53-2|53|6|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-53|AmOi-kBq 851,INII4AB/13+13b 11/73|1| 92|Am-241 oxide|851|kilobecquerels|Inhalation| 241 Gy inhaled|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-53-3|53|6|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-53|AmOi-kBq 851,INII4AB/13+13b 11/73|1| 92|Am-241 oxide|851|kilobecquerels|Inhalation| 241 Gy inhaled|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-53-4|53|7|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-53|AmOi-kBq 851,INII4AB/13+13b 11/73|1| 92|Am-241 oxide|851|kilobecquerels|Inhalation| 241 Gy inhaled|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-53-5|53|7|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-53|AmOi-kBq 851,INII4AB/13+13b 11/73|1| 92|Am-241 oxide|851|kilobecquerels|Inhalation| 241 Gy inhaled|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-53-6|53|9|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-1|54|475|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-2|54|503|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-3|54|510|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-4|54|544|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-5|54|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-6|54|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-7|54|580|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-8|54|632|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-9|54|637|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-10|54|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-11|54|699|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 551 - sarcoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|1| 92|Am-241 oxide|51|kilobecquerels|Inhalation| 14.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-12|54|785|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-1|54|475|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-2|54|503|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-3|54|510|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-4|54|544|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-5|54|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-6|54|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-7|54|580|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-8|54|632|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-9|54|637|Neoplasia malignant|Lower respiratory system|n/a|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-10|54|690|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-11|54|699|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 551 - sarcoma|
2-8-54|AmOiDT-kBq 51,INII4AB/14 11/73|2| 93|(Ca) DTPA|50|milligrams per kg animal|Injection, intraperitoneal| ip inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-54-12|54|785|Neoplasia malignant|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-1|55|237|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-2|55|252|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-3|55|347|Other deterministic changes|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-4|55|372|Other deterministic changes|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-5|55|422|Other deterministic changes|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-6|55|447|Other deterministic changes|Whole body|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-7|55|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-8|55|462|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-9|55|462|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-10|55|512|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-11|55|512|Neoplasia benign|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-12|55|512|Neoplasia benign|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-13|55|522|Neoplasia benign|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-14|55|532|Hyperplastic changes|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-15|55|542|Hyperplastic changes|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-16|55|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-17|55|542|Hyperplastic changes|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-18|55|562|Neoplasia malignant|Lower respiratory system|n/a|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-19|55|567|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-55|Pu8NOi-kBq 8.51,INIIIAB/1 8/71|1| 92|Pu-238 nitrate|8.51|kilobecquerels|Inhalation| 12.3 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-55-20|55|597|Other deterministic changes|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-1|56|282|Hyperplastic changes|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-2|56|290|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-3|56|333|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-4|56|333|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-5|56|334|Other deterministic changes|Whole body|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-6|56|335|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-7|56|335|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-8|56|337|Other deterministic changes|Whole body|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-9|56|344|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-10|56|345|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-11|56|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-12|56|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-13|56|422|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-14|56|457|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-15|56|467|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-16|56|472|Other deterministic changes|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-17|56|492|Other deterministic changes|Whole body|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-18|56|522|Other deterministic changes|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-19|56|564|Neoplasia malignant|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-20|56|564|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-21|56|570|Neoplasia benign|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-22|56|587|Neoplasia benign|Lower respiratory system|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-23|56|599|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-56|Pu8NOi-kBq 15.9,INIIIAB/3+4 71-73|1| 92|Pu-238 nitrate|15.9|kilobecquerels|Inhalation| 17.8 Gy inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-56-24|56|627|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-1|57|33|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-2|57|42|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-3|57|50|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-4|57|62|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-5|57|63|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-6|57|74|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-7|57|204|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-8|57|219|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-9|57|268|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-10|57|348|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-11|57|354|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-57|Pu8NOi-kBq 30.3,INIIIAB/5 4/73|1| 92|Pu-238 nitrate|30.3|kilobecquerels|Inhalation| 24.8 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-57-12|57|628|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-1|58|79|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-2|58|289|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-3|58|289|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-4|58|289|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-5|58|290|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-6|58|290|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-7|58|291|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-8|58|291|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-9|58|291|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-10|58|292|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-11|58|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-12|58|292|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-13|58|295|Other deterministic changes|Whole body|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-14|58|296|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-15|58|297|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-16|58|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-17|58|299|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-18|58|303|Hyperplastic changes|Lower respiratory system|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-19|58|326|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-20|58|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-21|58|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-22|58|347|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-23|58|430|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-24|58|508|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-25|58|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-26|58|522|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-27|58|637|Neoplasia benign|Lower respiratory system|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-28|58|651|Neoplasia malignant|Lower respiratory system|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-29|58|740|Neoplasia malignant|Lower respiratory system|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-30|58|740|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-31|58|747|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-32|58|765|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-33|58|770|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-8-58|Pu8Oi-kBq 1.22,INIIIAB/1+2+3 7/73|1| 92|Pu-238 dioxide|1.22|kilobecquerels|Inhalation| 2.6 Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-58-34|58|799|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-1|59|35|Hyperplastic changes|Lower respiratory system|n/a|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-2|59|208|Other deterministic changes|Whole body|n/a|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-3|59|315|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-4|59|332|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-5|59|372|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-6|59|442|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-7|59|442|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-8|59|467|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-9|59|541|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system| metastatic,MPATH: 551 - sarcoma|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-10|59|646|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-59|Pu8Oi-kBq 6.66,INIIIAB/4 8/73|1| 92|Pu-238 dioxide|6.66|kilobecquerels|Inhalation| 13.4 Gy inhaled|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-59-11|59|646|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-1|60|652|Other deterministic changes|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-2|60|652|Neoplasia malignant|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-3|60|652|Neoplasia malignant|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-4|60|652|Neoplasia malignant|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-5|60|662|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-6|60|662|Hyperplastic changes|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-7|60|692|Other deterministic changes|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-8|60|692|Neoplasia malignant|Lower respiratory system|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-9|60|692|Other deterministic changes|Whole body|n/a|
2-8-60|Pu9NOi-kBq 0.59,INIIIAB/3 4/70|1| 92|Pu-239 nitrate|0.59|kilobecquerels|Inhalation| 2.3 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-60-10|60|692|Other deterministic changes|Lower respiratory system|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-1|61|217|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-2|61|302|Neoplasia benign|Lower respiratory system|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-3|61|483|Hyperplastic changes|Lower respiratory system|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-4|61|507|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-5|61|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-6|61|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-7|61|555|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-8|61|592|Neoplasia malignant|Lower respiratory system|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-9|61|596|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-10|61|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-11|61|620|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-12|61|644|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-13|61|653|Neoplasia malignant|Lower respiratory system|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-14|61|656|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-15|61|668|Neoplasia malignant|Lower respiratory system|n/a|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-16|61|700|Neoplasia malignant|Lower respiratory system| metastatic lung tumour|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-17|61|710|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-18|61|711|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-19|61|716|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-61|Pu9NOi-kBq 8.81,INIIIAB/5 7/72|1| 92|Pu-239 nitrate|8.81|kilobecquerels|Inhalation| 27.1 Gy inhaled|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-61-20|61|716|Neoplasia malignant|Lower respiratory system|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-1|62|42|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-2|62|42|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-3|62|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-4|62|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-5|62|52|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-6|62|82|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-7|62|262|Neoplasia benign|Lower respiratory system|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-8|62|292|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-9|62|337|Neoplasia benign|Lower respiratory system|n/a|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-10|62|352|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-11|62|362|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-62|Pu9NOi-kBq 37,INIIIAB/4 12/71|1| 92|Pu-239 nitrate|37|kilobecquerels|Inhalation| 84.7 Gy inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-62-12|62|447|Neoplasia malignant|Lower respiratory system|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-1|63|44|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-2|63|53|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-3|63|53|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-4|63|60|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-5|63|60|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-6|63|67|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-7|63|67|Other deterministic changes|Whole body|n/a|
2-8-63|Pu9NOi-kBq 78,INIIIAB/1 5/69|1| 92|Pu-239 nitrate|78|kilobecquerels|Inhalation| 132 Gy inhaled|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-63-8|63|67|Other deterministic changes|Whole body|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-1|64|272|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-2|64|312|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-3|64|342|Other deterministic changes|Whole body|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-4|64|382|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-5|64|388|Other deterministic changes|Whole body|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-6|64|402|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-7|64|427|Hyperplastic changes|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-8|64|427|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-9|64|457|Hyperplastic changes|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-10|64|457|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-11|64|469|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-12|64|497|Other deterministic changes|Whole body|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-13|64|552|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-14|64|552|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-15|64|566|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-16|64|572|Neoplasia benign|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-17|64|610|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-18|64|622|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-19|64|631|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-20|64|646|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-21|64|652|Other deterministic changes|Whole body|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-22|64|657|Neoplasia malignant|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-23|64|665|Neoplasia malignant|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-24|64|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-25|64|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-26|64|706|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-27|64|725|Other deterministic changes|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-28|64|725|Neoplasia malignant|Lower respiratory system|n/a|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-29|64|736|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-30|64|770|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-64|Pu9Oi-kBq 1.63,INIIIAB/4 11/71|1| 92|Pu-239 dioxide|1.63|kilobecquerels|Inhalation| 9.3 Gy inhaled|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-64-31|64|770|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-1|65|24|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-2|65|82|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-3|65|192|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-4|65|217|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-5|65|277|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-6|65|282|Other deterministic changes|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-7|65|364|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-8|65|369|Neoplasia benign|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-9|65|369|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-10|65|402|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-11|65|432|Other deterministic changes|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-12|65|432|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-13|65|447|Neoplasia benign|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-14|65|452|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-15|65|462|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 549 - carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-16|65|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-17|65|492|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-18|65|517|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-19|65|532|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-20|65|557|Neoplasia malignant|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-21|65|572|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-22|65|617|Neoplasia malignant|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-23|65|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-24|65|632|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-25|65|632|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-26|65|657|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-27|65|662|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-28|65|680|Neoplasia malignant|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-29|65|732|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-30|65|732|Neoplasia malignant|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-31|65|732|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-32|65|732|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-33|65|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-34|65|777|Neoplasia malignant|Lower respiratory system|n/a|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-35|65|778|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-65|Pu9Oi-kBq 3.51,INIIIAB/RO48+79 70-71|1| 92|Pu-239 dioxide|3.51|kilobecquerels|Inhalation| 17.6 Gy inhaled|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-65-36|65|852|Neoplasia malignant|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-1|66|12|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-2|66|52|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-3|66|82|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-4|66|87|Other deterministic changes|Whole body|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-5|66|257|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-6|66|262|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-7|66|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-8|66|312|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-9|66|327|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-10|66|327|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-11|66|327|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-12|66|382|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-13|66|424|Hyperplastic changes|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-14|66|427|Neoplasia benign|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-15|66|437|Hyperplastic changes|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-16|66|457|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-17|66|457|Neoplasia benign|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-18|66|464|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-19|66|481|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-20|66|497|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-21|66|520|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-22|66|528|Neoplasia malignant|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-23|66|532|Neoplasia malignant|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-24|66|542|Neoplasia benign|Lower respiratory system,MA: 0000415 - lung|,MPATH: 240 - hemangioma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-25|66|557|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-26|66|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-27|66|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-28|66|618|Neoplasia benign|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-29|66|657|Neoplasia malignant|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-30|66|676|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-31|66|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-32|66|711|Neoplasia malignant|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-33|66|763|Neoplasia malignant|Lower respiratory system|n/a|
2-8-66|Pu9Oi-kBq 5.55,INIIIAB/791+2+3 11/71|1| 92|Pu-239 dioxide|5.55|kilobecquerels|Inhalation| 29.Gy inhaled|34 (34 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-66-34|66|806|Other deterministic changes|Whole body|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-1|67|212|Other deterministic changes|Whole body|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-2|67|257|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-3|67|297|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-4|67|302|Hyperplastic changes|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-5|67|312|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-6|67|312|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-7|67|312|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-8|67|362|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-9|67|362|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-10|67|372|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-11|67|372|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-12|67|372|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-13|67|382|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-14|67|382|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-15|67|382|Other deterministic changes|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-16|67|382|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-17|67|382|Neoplasia malignant|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-18|67|383|Other deterministic changes|Whole body|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-19|67|392|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-20|67|392|Neoplasia malignant|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-21|67|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-22|67|409|Other deterministic changes|Whole body|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-23|67|452|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-24|67|482|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-25|67|500|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-26|67|512|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-27|67|525|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-28|67|527|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-29|67|528|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-30|67|562|Hyperplastic changes|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-31|67|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-32|67|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-33|67|569|Neoplasia benign|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-34|67|572|Neoplasia malignant|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-35|67|572|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-36|67|572|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-37|67|573|Neoplasia benign|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-38|67|587|Neoplasia benign|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-39|67|605|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-40|67|617|Neoplasia malignant|Lower respiratory system|n/a|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-41|67|628|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-67|Pu9Oi-kBq 12.6,INIIIAB/Ro48+79 11/71|1| 92|Pu-239 dioxide|12.6|kilobecquerels|Inhalation| 70 Gy inhaled|42 (42 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-67-42|67|654|Neoplasia malignant|Lower respiratory system|n/a|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-1|68|82|Other deterministic changes|Whole body|n/a|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-2|68|82|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-3|68|82|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-4|68|82|Other deterministic changes|Whole body|n/a|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-5|68|192|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-6|68|222|Hyperplastic changes|Lower respiratory system|n/a|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-7|68|222|Hyperplastic changes|Lower respiratory system|n/a|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-8|68|232|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-9|68|232|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-8-68|Pu9Oi-kBq 29.4,INIIIAB/76 6/71|1| 92|Pu-239 dioxide|29.4|kilobecquerels|Inhalation| 94 Gy inhaled|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-68-10|68|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-1|69|25|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-2|69|29|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-3|69|30|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-4|69|30|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-5|69|44|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-6|69|44|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-7|69|45|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-8|69|47|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-9|69|52|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-10|69|52|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-11|69|52|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-12|69|52|Other deterministic changes|Whole body|n/a|
2-8-69|Pu9Oi-kBq 124,INIIIAB/13 3/71|1| 92|Pu-239 dioxide|124|kilobecquerels|Inhalation| 196 Gy inhaled|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-69-13|69|192|Other deterministic changes|Whole body|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-1|70|177|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-2|70|217|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-3|70|224|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-4|70|272|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-5|70|299|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-6|70|321|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-7|70|330|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-8|70|343|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-9|70|368|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-10|70|375|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-11|70|413|Other deterministic changes|Whole body|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-12|70|435|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-13|70|439|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-14|70|449|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-15|70|460|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-16|70|463|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| benign,MPATH: 549 - carcinoma|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-17|70|463|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-18|70|466|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-19|70|471|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-20|70|484|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-21|70|485|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-22|70|506|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-23|70|509|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-24|70|523|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-25|70|529|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-26|70|541|Other deterministic changes|Lower respiratory system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-27|70|565|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-70|Cmv-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-70-28|70|610|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-1|71|296|Other deterministic changes|Whole body|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-2|71|335|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-3|71|335|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-4|71|336|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-5|71|347|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-6|71|357|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-7|71|360|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-8|71|364|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-9|71|366|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-10|71|366|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-11|71|381|Other deterministic changes|Whole body|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-12|71|382|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-13|71|384|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-14|71|391|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-15|71|391|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-16|71|403|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-17|71|405|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-18|71|406|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-19|71|408|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-20|71|408|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-21|71|411|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-22|71|428|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-23|71|430|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-24|71|455|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-25|71|458|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle| benign,MPATH: 268 - adenocarcinoma|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-26|71|458|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle| benign,MPATH: 268 - adenocarcinoma|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-27|71|463|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-28|71|472|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-29|71|476|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-30|71|476|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-31|71|486|Other deterministic changes|Lower respiratory system|n/a|
2-8-71|Cmm-kBq 37,INJ2BG 4/75|1| 92|Cm-244 (?chemical form)|37|kilobecquerels|Injection, intramuscular| IM Injection|32 (32 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-71-32|71|536|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| metastatic,MPATH: 549 - carcinoma|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-1|72|133|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-2|72|133|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-3|72|165|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-4|72|180|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-5|72|186|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-6|72|189|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-7|72|195|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-8|72|206|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-9|72|208|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-10|72|216|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-11|72|224|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-12|72|226|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-13|72|230|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-14|72|230|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-15|72|238|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-16|72|244|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-17|72|246|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-18|72|246|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-19|72|256|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-20|72|271|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-21|72|279|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-22|72|279|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-23|72|284|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-24|72|285|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-25|72|286|Other deterministic changes|Lower respiratory system|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-26|72|324|Other deterministic changes|Whole body|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-27|72|392|Other deterministic changes|Whole body|n/a|
2-8-72|Amv-kBq 78,INJ2BG 4/75|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intravenous| IV Injection|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-72-28|72|397|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-1|73|192|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-2|73|230|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-3|73|251|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-4|73|258|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-5|73|259|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-6|73|260|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-7|73|265|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-8|73|280|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-9|73|280|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-10|73|284|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-11|73|285|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-12|73|285|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-13|73|294|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-14|73|294|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-15|73|296|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-16|73|300|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-17|73|301|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-18|73|314|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-19|73|318|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-20|73|322|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-21|73|333|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-22|73|342|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-23|73|344|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-24|73|356|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-25|73|357|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-26|73|362|Other deterministic changes|Whole body|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-27|73|368|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-28|73|368|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-29|73|399|Other deterministic changes|Whole body|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-30|73|422|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-31|73|427|Other deterministic changes|Lower respiratory system|n/a|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-32|73|434|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-73|Amm-kBq 78,INJ2BG 4/73|1| 92|Am-241 (?chemical form)|78|kilobecquerels|Injection, intramuscular| IM Injection|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-73-33|73|453|Other deterministic changes|Whole body|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-1|74|1|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland| metastatic,MPATH: 278 - follicular adenocarcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-2|74|1|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-3|74|14|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-4|74|15|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-5|74|15|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-6|74|18|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-7|74|18|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-8|74|23|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-9|74|25|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-10|74|61|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-11|74|89|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-12|74|91|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-13|74|481|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-14|74|486|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-15|74|502|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-16|74|575|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-17|74|594|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-18|74|607|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-19|74|653|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-20|74|691|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-21|74|698|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-22|74|704|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-23|74|718|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-24|74|718|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-25|74|729|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-26|74|732|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-27|74|751|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-28|74|766|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-29|74|773|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-30|74|774|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-31|74|799|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-32|74|802|Neoplasia malignant|Upper digestive tract,MA: 0000341 - oral region|,MPATH: 446 - squamous cell carcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-33|74|802|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-34|74|836|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-35|74|843|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-36|74|844|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-37|74|884|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-38|74|905|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-39|74|910|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-40|74|910|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-41|74|932|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-42|74|932|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-43|74|938|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-44|74|942|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-45|74|946|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-46|74|946|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-47|74|947|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-48|74|961|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-49|74|972|Other deterministic changes|Lower respiratory system|n/a|
2-8-74|Amm-kBq 0.111,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.111|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-74-50|74|1114|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-1|75|4|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-2|75|5|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-3|75|16|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-4|75|22|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-5|75|48|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-6|75|63|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-7|75|484|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-8|75|550|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-9|75|550|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-10|75|583|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-11|75|637|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-12|75|681|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-13|75|706|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-14|75|717|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-15|75|724|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-16|75|732|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-17|75|755|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-18|75|765|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-19|75|767|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-20|75|767|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-21|75|776|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-22|75|790|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-23|75|792|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-24|75|799|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-25|75|824|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-26|75|832|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-27|75|836|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-28|75|840|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-29|75|842|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-30|75|842|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-31|75|858|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-32|75|858|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-33|75|863|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-34|75|884|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-35|75|898|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-36|75|903|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-37|75|905|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-38|75|905|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-39|75|924|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-40|75|932|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-41|75|932|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-42|75|932|Neoplasia malignant|Other local manifestations and miscellaneus| metastatic|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-43|75|934|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-44|75|936|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-45|75|936|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-46|75|947|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-47|75|965|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland| metastatic,MPATH: 218 - neoplasm|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-48|75|966|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-49|75|974|Other deterministic changes|Lower respiratory system|n/a|
2-8-75|Amm-kBq 0.37,INJ2BG 10/79|1| 92|Am-241 (?chemical form)|0.37|kilobecquerels|Injection, intramuscular| IM Injection|50 (50 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-75-50|75|979|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-1|76|486|Other deterministic changes|Lower respiratory system|n/a|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-2|76|594|Other deterministic changes|Lower respiratory system|n/a|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-3|76|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-4|76|616|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-5|76|630|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system| benign,MPATH: 551 - sarcoma|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-6|76|633|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-7|76|633|Other deterministic changes|Lower respiratory system|n/a|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-8|76|652|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-9|76|675|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-76|Amm-kBq 1.11,INJ2BG 4/77|1| 92|Am-241 (?chemical form)|1.11|kilobecquerels|Injection, intramuscular| IM Injection|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-76-10|76|742|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-1|77|80|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-2|77|218|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-3|77|244|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-4|77|254|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-5|77|254|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-6|77|257|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-7|77|328|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-8|77|330|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-9|77|337|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-10|77|342|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-11|77|343|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-12|77|346|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-13|77|347|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-14|77|349|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-15|77|350|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-16|77|354|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-17|77|354|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-18|77|360|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-19|77|368|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-20|77|377|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-21|77|380|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-22|77|381|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-23|77|382|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-24|77|393|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-25|77|395|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-26|77|400|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-27|77|400|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-28|77|402|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-29|77|407|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-30|77|412|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-31|77|417|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-32|77|424|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-33|77|424|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-34|77|426|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-35|77|427|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-36|77|430|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-37|77|435|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-38|77|437|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-39|77|439|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue| metastatic lung tumour,MPATH: 212 - inflammation|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-40|77|442|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-41|77|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-42|77|444|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-43|77|444|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-44|77|449|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-45|77|451|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-46|77|453|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-47|77|453|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-48|77|457|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-49|77|461|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-50|77|461|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-51|77|462|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-52|77|462|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-53|77|463|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-54|77|464|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-55|77|466|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-56|77|467|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-57|77|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-58|77|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-59|77|473|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-60|77|481|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-61|77|482|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-62|77|482|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-63|77|483|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-64|77|484|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-65|77|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 255 - adenoacanthoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-66|77|489|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-67|77|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-68|77|492|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-69|77|492|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-70|77|492|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-71|77|500|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-72|77|501|Neoplasia malignant|Other local manifestations and miscellaneus| benign|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-73|77|501|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-74|77|502|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-75|77|502|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-76|77|503|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-77|77|503|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-78|77|503|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-79|77|504|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-80|77|505|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-81|77|506|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-82|77|509|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-83|77|509|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-84|77|510|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-85|77|510|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-86|77|515|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-87|77|515|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-88|77|516|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-89|77|516|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-90|77|517|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-91|77|517|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-92|77|518|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-93|77|519|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-94|77|521|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-95|77|522|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-96|77|522|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-97|77|523|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-98|77|523|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-99|77|524|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-100|77|525|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-101|77|526|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-102|77|527|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-103|77|530|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-104|77|534|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-105|77|534|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-106|77|535|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-107|77|536|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-108|77|537|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-109|77|538|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-110|77|538|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-111|77|538|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-112|77|538|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-113|77|539|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-114|77|540|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-115|77|542|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-116|77|543|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-117|77|545|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-118|77|545|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-119|77|548|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-120|77|551|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-121|77|555|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-122|77|555|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-123|77|557|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-124|77|559|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-125|77|560|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-126|77|561|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-127|77|563|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-128|77|564|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-129|77|565|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-130|77|565|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-131|77|566|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-132|77|566|Neoplasia malignant|Liver among hepato-pancreatic system diseases| benign|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-133|77|566|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-134|77|567|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-135|77|567|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-136|77|568|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-137|77|569|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland| benign,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-138|77|572|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-139|77|573|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-140|77|573|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-141|77|573|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-142|77|574|Neoplasia systemic|Haematolymphatic system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-143|77|574|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-144|77|577|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-145|77|577|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-146|77|577|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-147|77|580|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-148|77|581|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-149|77|581|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-150|77|586|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-151|77|587|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| metastatic,MPATH: 408 - soft tissue fibrosarcoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-152|77|588|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-153|77|588|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-154|77|588|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-155|77|591|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-156|77|591|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas| benign,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-157|77|592|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-158|77|594|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-159|77|596|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-160|77|597|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-161|77|598|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-162|77|599|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-163|77|600|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-164|77|601|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-165|77|603|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-166|77|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-167|77|609|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-168|77|609|Neoplasia malignant|Liver among hepato-pancreatic system diseases| benign|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-169|77|612|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-170|77|612|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-171|77|613|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-172|77|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-173|77|613|Other deterministic changes|Lower respiratory system|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-174|77|615|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-175|77|615|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-176|77|615|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-177|77|615|Other deterministic changes|Whole body|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-178|77|621|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-179|77|621|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-180|77|622|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung| metastatic lung tumour,MPATH: 549 - carcinoma|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-181|77|626|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-182|77|630|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-183|77|648|Neoplasia malignant|Bone among musculo-skeletal system diseases| metastatic|
2-8-77|Amm-kBq 6.66,INJ2BG 6/77|1| 92|Am-241 (?chemical form)|6.66|kilobecquerels|Injection, intramuscular| IM Injection|184 (184 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-8-77-184|77|657|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system| benign,MPATH: 408 - soft tissue fibrosarcoma|
		
